NASDAQ · AHG
Akso Health Group ADS financials
$0.6910−5.47%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 |
|---|---|---|---|---|---|
| Revenue | $13.8M | $14.8M | $2.4M | $13.2M | $6.0M |
| Gross profit | -$11.3K | -$281.5K | $122.1K | $1.3M | $605.1K |
| Gross margin | −0.1% | −1.9% | 5.1% | 9.6% | 10.1% |
| Operating income | -$20.7M | -$166.3M | -$8.6M | -$14.3M | -$2.5M |
| Net income | -$18.7M | -$135.0M | -$9.5M | -$1.4M | -$16.9M |
| Net margin | −135.0% | −913.4% | −391.8% | −10.3% | −280.9% |
| Diluted EPS | $-0.01 | $-0.16 | $-0.07 | $-0.02 | $-0.28 |
| EBITDA | -$1.6M | -$1.8M | -$8.6M | -$14.3M | -$2.5M |
| Operating cash flow | -$12.8M | $1.2M | $1.4M | -$3.3M | -$8.6M |
| Free cash flow | -$12.8M | $1.0M | $1.4M | -$3.3M | -$8.6M |
| Diluted shares | 2,168.1M | 855.3M | 141.5M | 68.6M | 59.6M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $170.6K | $176.2M | $85.2M | $7.9M | $18.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $350.5K | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $189.6M | $215.0M | $142.0M | $20.5M | $62.8M |
| Total liabilities | $8.7M | $15.8M | $3.6M | $11.6M | $50.5M |
| Shareholders' equity | $180.9M | $199.2M | $138.4M | $8.8M | $12.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology